Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience
- 8 October 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (43), 7123-7129
- https://doi.org/10.1016/j.vaccine.2010.07.028
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Accelerating Policy Decisions to Adopt Haemophilus influenzae Type b Vaccine: A Global, Multivariable AnalysisPLoS Medicine, 2010
- Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimatesThe Lancet, 2009
- Economic evaluations ofHaemophilus influenzaetype b vaccine: systematic review of the literatureExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Progress in Vaccination against Haemophilus influenzae type b in the AmericasPLoS Medicine, 2008
- Introduction of Hib vaccine into national immunization programmes: A descriptive analysis of global trendsVaccine, 2007
- Rapid Assessment Tool forHaemophilus influenzaetype b Disease in Developing Countries1Emerging Infectious Diseases, 2004
- Global reduction of Hib disease: what are the next steps? Proceedings of the meeting: Scottsdale, Arizona, September 22-25, 2002The Journal of Pediatrics, 2003
- Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four ‘newly adopting’ countriesVaccine, 1999
- The introduction of new vaccines into developing countriesVaccine, 1999